Valerion Therapeutics' Grant

Valerion Therapeutics raised a round of funding on May 06, 2010. Investors include Muscular Dystrophy Association.

Valerion Therapeutics, formelry 4s3 Bioscience, is a biotechnology company focused on developing genetic disease therapies for orphan neuromuscular disorders. The company's platform is an antibody-bas…

Articles about Valerion Therapeutics' Grant: